Cifrazol
Product Images NDC 69336-310

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cifrazol (NDC 69336-310). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sterling Knight Pharmaceuticals,llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Form (Cifform)

Chemical structure diagram showing a complex organic molecule, likely representing the active ingredient of Cifrazol by Sterling Knight Pharmaceuticals, LLC. The structure features multiple ring systems, double bonds, and several methyl groups, typical of steroid-like compounds.*

FDA Label Image

Carton (Cifrazol)

This drug facts panel for Cifrazol by Sterling Knight Pharmaceuticals, LLC provides dosage instructions, including typical adult dosing of one capsule daily. It lists warnings, allergen information, and storage conditions. The description covers Cifrazol as an oral prescription vitamin with folic acid and cholecalciferol (vitamin D3) active ingredients, dosage form, and capsule imprint details. Additional inactive ingredients and regulatory notes are also included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.